H.C. Wainwright raised the firm’s price target on Dynavax to $28 from $27 and keeps a Buy rating on the shares. The analyst cites increased sales estimates post the Q3 report for the target dump.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DVAX: